Pathophysiology of levodopa-induced dyskinesia: potential for new therapies
- PMID: 11484001
- DOI: 10.1038/35086062
Pathophysiology of levodopa-induced dyskinesia: potential for new therapies
Abstract
Involuntary movements--or dyskinesias--are a debilitating complication of levodopa therapy for Parkinson's disease, and is experienced in most patients. Despite the importance of this problem, little was known about the cause of dyskinesia until recently; however, this situation has changed significantly in the past few years. Our increased understanding of levodopa-induced dyskinesia is not only valuable for improving patient care, but also in providing us with new insights into the functional organization of the basal ganglia and motor systems.
Similar articles
-
[Pathophysiology and therapy of L-Dopa-induced dyskinesia].Rev Neurol (Paris). 2003 Dec;159(12):1125-42. Rev Neurol (Paris). 2003. PMID: 14978413 Review. French.
-
[Understanding and treating levodopa-induced dyskinesias].Tunis Med. 1998 Dec;76(12):437-47. Tunis Med. 1998. PMID: 10093483 Review. French. No abstract available.
-
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S25-9. doi: 10.1016/j.parkreldis.2004.11.005. Parkinsonism Relat Disord. 2005. PMID: 15885624 Review.
-
New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.Adv Neurol. 2003;91:51-64. Adv Neurol. 2003. PMID: 12442663 Review. No abstract available.
-
Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.Prog Brain Res. 2008;172:479-94. doi: 10.1016/S0079-6123(08)00923-0. Prog Brain Res. 2008. PMID: 18772047 Review.
Cited by
-
Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications.Int J Neuropsychopharmacol. 2016 Apr 2;19(10):pyw030. doi: 10.1093/ijnp/pyw030. Int J Neuropsychopharmacol. 2016. PMID: 27037577 Free PMC article.
-
Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys.Cell Transplant. 2013;22(5):831-8. doi: 10.3727/096368912X647144. Cell Transplant. 2013. PMID: 23594934 Free PMC article.
-
Clinical aspects and management of levodopa-induced dyskinesia.Parkinsons Dis. 2012;2012:745947. doi: 10.1155/2012/745947. Epub 2012 Jun 3. Parkinsons Dis. 2012. PMID: 22701811 Free PMC article.
-
Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trial.BMC Neurol. 2007 Jul 16;7:20. doi: 10.1186/1471-2377-7-20. BMC Neurol. 2007. PMID: 17634109 Free PMC article. Clinical Trial.
-
Association of Depression With Early Occurrence of Postural Instability in Parkinson's Disease.J Mov Disord. 2023 Jan;16(1):68-78. doi: 10.14802/jmd.22091. Epub 2022 Dec 20. J Mov Disord. 2023. PMID: 36537065 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous